Early intravenous administration of metoprolol enhances myocardial salvage by thrombolysis with recombinant tissue-type plasminogen activator after thrombotic coronary artery occlusion in the dog by improvement of the collateral blood flow to the area at risk  by Zmudka, Krzysztof et al.
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Objmtiws. We studied the effects OF beta,.adremrgic Mo&ade 
pmced&g tkmmbd& 00 kemcdywmdc variabks, mywardkd 
bkmd tlow eed iefarct size lo P canine model of tkromtmtic 
admios eftbe kft mderior descendbtg coronary artery. 
MUha&. Eqwkneets wre cneducted in 34 uneslbetiztd ogs; 
I7 mxiwd 0.975 m&g body weiglst al metopdol iokwcnously 
starthg 15 I&I after c-xhtsh. and thmmbolysis was lnittated 
60 ala after ocdwkm. Seventeen dogs received saliie solutlw 
ldlewd by tbremlx4ys&. Comnery blood Row was meawed by 
ndkactive micmqkens, ktferrt size by e dye method. bawdy- 
eemic rev&~ by c&eter.tippd pressure transdunlm sod 
adiec matpet by tke tkmwdilutlrm metbad. 
Resti. l&ret site kl saopmtot- and pta.xbo.treated do&s 
was 23.62 * 18.04% end 41.50 f 16.03% of srea at risk, 
mspretirdy (p < 0.01). Before occluriao, mymvdipl blood Sow 
Studies on early ndministration of beta-ad&energic blocking 
agents preceding timely repelfusion in a-lmal models of 
acute &ionel myocardial &hernia demonstnted a limita- 
tion in infarct size (l-3). The salvaae of myocardium has 
been atttibuted to a reduction in my&dial oxygen demand 
(4-6). a decrease in plasma catechala&e concentration. a 
decrease in sympathetic twvotts activity (7.81, alterations of 
myocwdid substrate utilizaticn (9.10). cell and lysosomal 
membrane stabilization (7,l II. reduction of microvascular 
damage (12) and a redistribution of blood Row to the isch- 
emit region (4). 
and kemodgnamic variables were simltar. Sixty minutff after 
wctuaien. cardiac uotwt (1.94 + 0.41 vs. 2.36 + 0.68 titersinrin. 
p < O.Oi) ws lowrr’ia & mlapmkd-treated dogs. CoMeti 
flow to the fvea at rhk (17.27 * 7.44 vs. 10.25 + S.33) and to its 
epicardial(21.6S * !Mlvs. 11.5 * 6.10). ~rny~~ia~(l4.~* 
5.34 cm’/min per 100 g) layers was biikr (p c 0.05) in the 
metopmlul.treated da@. The ratio ot epkwdtal Row area at 
risklcirrumtlcr territory was inversely ewnlsted to itiarct sire 
(I = -0.69, p < 0.01). AtIer S min d wxiusion, c&iteRI Row 
“9s comparable in the Ave dogs of eack gmup; crer the next 
55 min it remained m&ant in the mctopmlol group but d-4 
in the placebo dqs. 
Conclwians. intravenous metoprokd, administered before 
tkmmbolysis, enhances infarct size timibltion, partly by impmve- 
men, of rollateral Row to area at risk. 
(I Am Cell Cordial 1w4;23:14t%Sw 
Previous studies from our laboratory have suggested that 
intravenous administration of metopmlol preceding tbmm- 
bolysis with recombinant issue-type plasminogen nctivator 
@t-PA) had a favorable effect on left ventricular function and 
infarct size in a dog model of acute thrombotic occlusion of 
the left anterior descending coronary artery (13.14). The 
present study examines in th: same model the combined 
effects of intravenous metoprolol administration and throm- 
bolysis with rt-PA on coronary blood flow, hemodynamic 
findings and mfarct size and their interrelation. 
Methods 
Study animals. We studied 34 mongrel male and female 
dogs wkighing between I7 and 30 kg. Dogs were premedi- 
cated bv an intramuscular iniection of a combination of 
Ruaniso& and fenranyl citrath(~ypnono. 0.25 m&kg body 
weight). Anesthesia was induced by slow intravenous ad- 
ministration of sodium pentobarbital (Nembutal) in a dose of 
30 tr&%g and was maiataiaed by continuous infusion of 
oeatobarbital. 6 m&a uer h in Rioaer’s solution. at a rate of 
30 ml/h. Do& were v&lated witha Bird respirator. Aortic 
and left ventricular oressures were monitored tbroaah a 
Millar dual sensor catheter (model WC 181X BP). Ele&o- 
cardioaram (ECG) lead U and aoriic and IeR ventricular 
pressures were recorded sittadtaoao~sly on a Hewlett- 
Packard Vectra RS/20 computer. Heart rate, systolic aad 
diastolic pressures, pressure derivatives and surfaces under 
the pressure carves were determined automatically. Tension 
time index was calculated as the product of the surface under 
the aortic systolic pressure carve and the heart rate. Dia- 
stolic pressure time index was defined as the product ofthe 
area between the aortic aad letI ventricohu pressare carves 
during diastole and heart rate. A Swan-Gana catheter was 
posit&d in the pulmonary artcry. Cardiac output was 
measured by the thermodilution techniaue Wawlett-Packard 
Cardiac Output Module 782310. Themean of three stable 
values was taken. 
Regional left ventricular blood Row was measured by the 
radioactive m&spheres technique. Microspheres were iw 
jetted through a pigtail 7F catheter into the left ventricular 
cavity W6). The microspheres were labeled with four 
diierent radioactive nuclidcs: cerhtm-141. ruthenium-103, 
niobium-9s and tin-l I3 (Da Pont NEN-Trac micros~herea). 
The mean (*SD) size’of the microspheres was~l5.5 1 
0.1 pm. At the end of the experiment the heart was arrested 
by injection of a saturated solution of potassium chloride 
into the aortic root. The left anterior coronary artery distal to 
the occlusion site was cannulated. perfused aad stimd with 
a solution of 2,3,5-lriphenyl-2H~ietraaolium chloride at a 
pressure of 80 to 120 mm Hg; at the same time the ostia of 
both coronary arteries were cannulated and petfoxd at the 
same pressure with a solution of Evans blue. The Iell 
ventricle was dissected free and cot into l-cm thick slices. 
Color pictures of the upper side of each slice were obtained, 
and the contours of the left ventricular ring, the area at risk, 
noarisk area and necrotic areas were reproduced with black 
ink on traasparent plastic sheets. Infarct 1.0 imaging soft- 
ware (S.I.D. Jaossen Pharmaceutics N.V.) was used for 
planimerric estimation of infarct size (17). ThereaRer. tissue 
samples were taken from the nonrisk area and the area at 
risk. The radioactivity of the reference blood sample and 
mywudial tissue was determined by a gamma-counter 
(analyzer model 45. Molsgsard Medical) connected to ao ND 
680 programmable analyzer/computer system (Nuclear Data 
GmbH). Regional myocardial blood flow was calculated by 
averaging the flow of all samples from aa individual tissue 
region. Total myocardial blood flows were ca!x!ated as the 
sum of Row in each sample belonging to the rt@an (16,17). 
Experl~otal pmtocol. After instrumentation, a 30min 
stabilization period was allowed, followed by thrombotic 
occlusion of the midsegment of left anterior descending 
coronary artery by the copper coil technique (18,19). Corn-- 
nary occlusion, angiographically confirmed. occurred in ali 
animals within IO min. Thereafler, the animals were random- 
ized to receive metoprolol (a = 17) or placebo (n = 17). 
Metoprolol, 0.3 mpnCg bolus injection followed by aa iefa- 
sion of 0.3 me/kg per h, was started IS ado after occlusion 
and contioued untU the end ofthe experiment. The total dose 
of metoprolol at the end of the experiment was 0.975 m& 
At the cod of occlusion each dog had received 0.525 mgikg 
metoprolol intravenously. Thmmbolysis with R-PA, IO 4 
tin per kg, was stattad @I ado after occlusion aod lasted 
3Omin. Onset ofnatision was evaluated every 10 mia aad 
occurred in all a&.als between IO sod 20 &a, sod the 
copper coil was removed 30 ado after the onset of reperfb- 
aion. Aa~pbically tbe vessel was completely open. 
Antithrombetic therapy was not administered. Hemody- 
aamic and coroaary Row mewrements were performed at 
the end of the stiiliition period and after 60 mio of 
occlusion. In IO @. randomly selected Oive ia the meto- 
prolol group. five in the coatrol groop), additional wasore- 
mats were made 5: min after occlasion, before drag admin- 
iatratioa. 
Sulsskd malyds. Raodomizatioo was perforoxd by a 
computerized prccedurc. Data are prewwd as mcaa value 
? SD. Observatioos in drug pad placebo gmops were 
compared by the unpaired r test for aormally distributed 
variables and by the Maon-WhitoeyWikoxoa test for oth- 
en. For within-groap comparisotw the @red r test was 
used. A p valw do.05 ~0s co&lend s@iftwd. Linear 
regression analysis was performed. All statistical c&da- 
tbms were pcrforraed on a Hewktt.P&iard Vectra R.S!iil 
persooal colnprter with the SAS statistical pa&a& 
Resultr 
lfcmcdymmJenmllmp.Thehemcdynamicfindinpin 
both groaps were similar at the end of the s(nbili2arma 
peri& Mer 60 min of occlusion, cardiac output was lower 
ia the metopmlol gmup: I.94 ?: 0.41 wnus 2.32 f 0.68 
litcrs!min (p < 0.01). Heart rate, stroke volume. aortic and 
*R vent&alar pfessares. tension time inden aod diastolic 
tension i&x wen similar. Peak positive first derivadve of 
left vcntrktdar and ax-tic pressure (dP/dt) tended to k 
lower; peak negative dP/dt was somewhat higher in the 
metoprolol gmttp (Tabk 1). 
Ra8bwlm~MoadRowdar@amlrd@odamd 
afler6Dr&ef~.TheregionrlmyowrdiaJbloud 
Row to the total area at risk befw thrombotic occlusion was 
55.32 + 20.4 sod 53.21 f 18.45 ml!min per 108 8 in the 
mctoprolol and placebo groups, respectively; corresponding 
values for the left circumtka conmary artery territory were 
58.62 f 23.27 aad 504 + 21.32 o&in per 100 g. After 
60 rain of occlusioa. blood Row in the territory of the IeR 
(Table 2). The end&dikpicardial~blood Sow 
ever, was higher in the metoprold group WO * 0.17 vs. 
1.32 + 0.16, p C 0.01). Collateral blood Row to the total area 
at risk as well as to its epicardial, midmyocardi aad 
endocardial layers was higher in the metoptulol group (Tabk 
2). The ratio of endocaniird to epicardial collateral blood 
llow wan similar ic bath groups. Collatenl blcad flow was 
highest in viable ischemic qions. lowest in necrow tissue 
and intemwdiate in patchy necmtic tissue (Table 3). In the 
three myocadial layers. Mood Row to tissue of each viability 
category was higher. but not si&Icaatly, in the metopmlol 
gmup. The ratio of area at riskkiwmflex territory blood 
ftow was biir in tbe metopmlol-treated dogs in each 
myocardial layer. Linear regression analysis revealed a 
skgnificant negative correlation between the ratm of epicar- 
dial area at riskkcircumflex territory blood flow at&r 60 min 
of occlusion and infarct size expressed as percent of the area 
at risk (r = -0.69. p C 0.01) (Fig. I). Separate analyses of 
the placebo and metoprolol goups were performed; a sig- 
nificance test for both regression coetlicients did not permit 
rejection of the hypothesis that both were equal. Hemody- 
namic variables. including tension time index and other 
variables of re&xtal blood flow to the area at risk definitely 
showed B less significant correlation with infarct size. 
Re@~l myowdlnl btmd tlow &e~ S mtn al e&wico. 
In five animals of each group regional myowdial blood flow 
was determined 5 min after occlusion, IO min before admiw 
istration of metoprolol. In bath groups blood Row to the 
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Flgurc 1. Correlation beiween the ratioof epicardial blood Row area 
at risk/circumflex territory (ordinate) and infarct size expressed as 
percent ofthe area al risk (abs&sa~. SdM sqttnrcs = pkxehogroup; 
open sqwes = mctoprolol group. 
circumflex territory was comparable after J min of occlu- 
sion, and a similar nonsignificant decrease occurred after 
60 min. After 5 min of occlusion, total collateral Row was 
similar in both groups, hut after60 min it tended to decrease 
in the placebo but not in the metoprolol group (p > 0.05). 
This tendency was observed in the three myocardial layers 
of placebo-treated animals (p z 0.05). The ratio of cndocar- 
dial/epicardial flow remained unchanged in the metoprolol 
group but decreased in the p!acebo group (p = 0.04). The 
ratio of blond Row to the total area at risk/total circumflex 
territory and to each of their layers tended IO increase in 11,: 
metoprolol group but to decrease in the placebo group. For 
the epicardial myocardium this ratio was significantly lower 
in rhe placebo group than in the metoprolol group (p < 0.05) 
(Table 4). 
Infarct size. The size of the area at risk was similar in 
both groups: 31.75 2 19.83% of the left ventricle in the 
metoprolol group and 30.29 i 17.36% in the placebo group. 
Infarct size e:rpressed as a percent of the area at risk was 
lower in the metoprolol group: 23.62 2 I&04% versus 
4153 + 16.03% (p 4 0.01). 
Diiussion 
Previous work, Early intravenous beta-blockade preced- 
ing timely rep&&ion bas been shown in expetimental 
coronary occlusion to enhance the limitation of infarct size 
obtained by repecfusion atone (I-3). Previous work by our 
group showed that intravenous administration of metonro!ol, 
0.5 mglkg, 15 tin after thrombotic occlusion of the left 
anterior descending coronary artery in the anesthetized dog 
enhanced the effects of thromholysis with rt-PA HI min after 
occlusion on infarct size and left ventricdar function evalv 
ated 24 h and 1 week later (13.14). The present study 
confirms the effects of metoprolol combined with thrombol- 
ysis on infarct size (14): The infarct size is reduced from 
-4W?& of the area at risk to 20%. 
Hemcdynandc tindh~gs. In both treatment groups, the 
hemodynamic findings were similar before thmmbotic occlu- 
sion and at the end of a Mmin occlusion period, except for 
cardiac output, which was significantly lower in the meto- 
prolol group, suggesling a negative inotfopic effect. Because 
tension lime index and index of oxygen consumption were 
similar in both groups, the negative inotropic effect of 
metoprolol was not marked. Sirry minutes after occlusion 
the treatment group bad received a total dose ofO.525 m@g 
of metoprolol intravenously. A negative chronotropic effect 
did not occur, and fhis may be related to the low heart rates 
in the present study (20). Diastolic tension time index and its 
ratio 10 tension time index remained unchanged, suggesting 
that the driving force for blood flow was unaltered by 
meioprolol treatment (21). 
CoWeralblaad#ouafterlhofoalwioo.Tbepresent 
study shows that I h after tbrombotic occlusion of the left 
anterior descending coronary artery, total collateral blood 
flow to the area at risk was signilicantly higher in metoprolol- 
treated animals. This difference was present in tbe cpicar- 
dial, midmyocardiai and endocardipl layers of the myocar- 
dium. Some previous investigators dii not observe an 
‘fable 4. Regional Myocardial Blood Flow 5 nnd 60 min After Occlusion of the LetI Anterior Dercendina Coronary Artery 
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16.22 f 26.38 53.69 f 28.89 NS 68.10 z 27.16 52.19 t 11.41 NS 
ts.as f 7.86 13.89 t 1.12 NS 14.41 2 8.59 8.31 I 3.44 NS 
0.20 + 0.07 0.27 I 0.08 NS 0.21 5 0.11 0.18 t at3 NS 
22.19 f 11.85 20.62 * 9.51 NS 1502 3 a.94 9.n % 2.88 NS 
Il.49 f 8.42 IO.24 18.24 NS 13.13 2 9.19 5.13 t 3.a NS 
11.81 2 7.17 to.81 = 8.55 NS 10x4 z 7.93 3.70 I 3.04 NS 
D.51 ? 0.23 0.47 r 0.19 NS 0.68 2 0.37 0.4a t 0.30 O.oC 
0.33 f 0.08 0.45 * 0.10 NS 0.25 ? 0.07 0.23 f 0.w NS 
0.15 i 0.08 6.18 2 0.0s NS 0.17~0.10 0.12 t 0.11 NS 
Endo 0.13 * 0.06 0.16 t 0.08 NS 0.13 s 0.07 0.07 t 0.08 NS 
“ata pzsented are mean values * SD. explored in mUmin per Iw 8. ‘Sigifcantly diktnt (p = 0.005I fmm WlPpmlol grwp. Abbrrvtins a3 in 
Table 2. 
increase in collateral blood flow after beta-blockade (2.22). 
Fox et al. (23) reported a progrcnivc increase in collateral 
flow to the area at risk in dogs treated with propranolol. In 
the conscious dog, Vatner et al. (20) observed a” increase in 
collateral Row to the moderately severely ischemic zone 
after intravenous administration of propranolol. 
I” the normally perfused circumflex territory. total myo- 
cardial bled Row was similar despite the administration of a 
beta-blocker in the metopmlol group. which suggests, as 
previously alluded to, the absence of major diierences in 
global left ventricular oxygen consumption between treat- 
ment groups. Di&re”ces in myocantial blood supply to the 
circunllex territory nevertheless accutxd. because, as has 
atso bee” shown by others (20). after beta-blockade the ratio 
of endwardiaUe”icardizd flow increased in nonischemic 
mywardium. . 
The higher ratio of area at risk/circumflex artery blood 
Raw in ischemic tissue indicates a redistribution of blood 
flow from the ttonischemic lo the ischemic myocardium. As 
a consequence, blood Raw lo the viable patchy necrotic and 
nccmiic tissue was higher in metoprolol-treated dogs. A 
si@cant neptive correlation between the IXKI of area at 
tisWcirc”mRex artery epicardial collateral Row and infarct 
size expressed as a percent of the area at risk sugests th”t 
this redistribution plays a” important role in the enhance: 
survival of myocardium. One hour after occlusion of the left 
anterior descending coronary artery. the area at risk is 
akinetic or dyskinetic, eve” in animals treated with beta- 
blockers (2,20). Oxygen consumption in the viable tissue al 
that time is low, and a” increase in oxygen supply by even a 
sU& enhsncemcnt of colla~eml blwd Row miaht improve 
Gvival of myocylcs. 
Cd4ewal hloed lbw after 5 min of wclusiott. Cornnary 
blood Row to the circ”“tllex territary decreased to the same 
extent in both grwps from 5 to 66 min after occlusion. This 
decrease is very likely &led to the &cts of general 
anesthesia. Although differences were not significant be- 
cawe of the lit&ted “umber of observations. collateral blcad 
Bow to all layers of the area at risk decreased in the 
placebwwted animals from 5 to 60 min after occlusion. 
especially in the subendofardial region. as reflected by the 
signiticrmt decrease in the ratio of sube”docardiaUepicardial 
blood Row. Most previous workers found that collatenl 
blood flow to the area at risk in ““treated dogs remains 
stable from 5 min to 6 h after occlusion (2.20.22.24). When 
myoardii bled Row was measured immediately after 
occlusion (23,25), a” increase in collateral flow with time 
was observed. Our data. however, suggest that in control 
dogs blood flow decreased from 5 mi” t” M) min atIe1 
occlusion mainly in the s”bendocardi”m. possibly as a 
consequence of cell death and microvascular damage. Afta 
beta-blockade Vatner et al. (201 and Fox et al. (23) observed 
a” increase in collateral flow. I” the present study a stabili. 
latio” of total bled Row t” the area at risk occurred, but 
with evidence for redistribution of Raw from the “onisch. 
emit to the ischemic myocardium. The reasons for these 
differences iire ““clw. 
Mechanisms of e”ba”xalent of eollaterpl Bow by meto- 
prolol. Collateral Row to the area at risk is dependent on the 
aortic driving pressure, heart rate, the size of the inchemic 
area. the resistance in the segments of the donor artery 
proximal to and in the resistance vessels distal 1” the origin 
of the collateral vessels. the number and diameter of the 
collateral vessels at each moment atIer occlusion and SIC 
resistance in the micrccirculario” of the area at risk. Heart 
rate. diastolic pressure time index, systolic and diastolic 
ax-tic and left vcntncular presnl,~._ . *-- -.td !he ar*e at risk were 
similar in horh groups. 
Beta-blockade mi8h! increase diving force by decreasing 
heart rate and augmenting diastolic tension time index, hut 
this was not the case in the present study. Negative inotmpic 
effects of metoomlol could have decreased shortenins and 
compressive f&es in the ischemic area (220) and f&wed 
collateral Row: but. it might also have decreased ony8e” 
requirements and. by autoregulatary mechanisms (26). in- 
creased resistance in the microcirculatia” of the area at risk. 
However. it is unlikely that these mechanisms played a 
definite role in the present study because no clear negative 
inotropic effects were observed. A higher dosw of met* 
or&l might have elicited a cleorcr negative inotmpic effect. 
‘Beta-blockade may increase the resis&e of the &tance 
vessels in the circumflex terrilory (27) and so augment 
driving pressure for the collateral vessels. A direct protec- 
five effect of mctopmlol on the micmcirculation of the area 
at risk may have reduced pmgressivc: damage to small 
vessels and capillaries (28) and prevented the decline of 
collatetal flow. Epicardial coronary vessels and mature 
collateral vessels possess beta,- and beK+receptors (29). 
The extent to which beta,-blockade of these receptors 
played a role remains u~lcar. 
Influence of metoprea 0” other CnrdhJprewive “t&la. 
“isms. Our findings do not suggest that a reduction in 
myocwdial oxygen consumption in the area at risk through 
beta,.blockade was the major reason for the preservation of 
myofardium during cornnary occlusion followed by repetfu- 
Sian. A reduction in oxygen consumption leads. by autoret? 
uiatory mechanisms (26). to a decrease in myowdial flow. 
Mechanisms such as direct cytopratective ffects and meta- 
bolic alterations very likely played a role (30.31) and ampli- 
fied the effects of enhanced collateral blood flow. Rcwfu- 
sion injury may influence the final extent of my&dial 
necrosis (32). It remains unclear, however. whether beta- 
blockade istluences the suecitic deleterious effect of reper- 
fusion (33). 
Relevance to ac”te my”eadial infarction in humans. Re- 
cent work by our groop (34) on acute myocardial infarction 
in humans could “of confirm the present findings in the dog. 
Intravenous administration of atcn”lol preceding thrombol- 
ysis with e-PA had no effect o” e”zym&c and siintigraphic 
infarct size end on global and regional left ventricular 
function in patients with awte myocardial infarction without 
contraindications to beta-receptor block&. Similar findings 
have been reported by other invMigators (35). Many fat- 
tols, including ga~eral anesthesia, the absence of progres- 
sive coronary lesions. the abruptness and duration ofocclu- 
sion, the timing and dosage of metoprolol administration. tbe 
completeness of thrombolysis and diierenc.cs ktwecn the 
canine and human coronary circulation. may explain these 
diEerences. However, it is not impossible that, in humans. 
beta-blockade could play a role in aate myocardial i&c- 
tion that is treated very early after onpet. 
